Study evaluates biomarker criteria for assessing Alzheimer’s risk
One of the biggest challenges in Alzheimer’s research is to identify biomarkers that can identify people who are at risk […]
NEW YORK (Reuters Health) – Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction […] Researchers have uncovered pathways involved in the body’s response to glucocorticoid treatments and identified a novel biomarker that could be […] NEW YORK (Reuters Staff) – Using serum metabolomics profiling, researchers have identified two metabolites that are associated with risk for […] A new biomarker discovered by a team that includes researchers from Penn Medicine identifies patients with an aggressive form of […] A new, objective way of measuring flavanol intake has been developed, which could help nutritional experts assess the link between […]Biomarker
Pembrolizumab May Be Preferable to Chemo in Certain Patients
Novel biomarker for glucocorticoids could help tailor treatments
Serum Biomarkers of Increased Risk for Second Primary Lung Cancer Identified
New biomarker identifies patients with aggressive lymphoma who don’t respond to precision therapy
Biomarker provides accurate measurement of flavanol intake